APPLICATION
ANDA076164
TYPE
ANDA
ORIGINAL APPROVAL
2002-07-01
LATEST ACTION
2020-05-28
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Prescription
Products
LISINOPRILPrescription
LISINOPRIL 5MG · TABLET · ORAL
LISINOPRILPrescription
LISINOPRIL 40MG · TABLET · ORAL
LISINOPRILPrescription
LISINOPRIL 20MG · TABLET · ORAL
LISINOPRILPrescription
LISINOPRIL 10MG · TABLET · ORAL
LISINOPRILPrescription
LISINOPRIL 2.5MG · TABLET · ORAL
LISINOPRILPrescription
LISINOPRIL 30MG · TABLET · ORAL
Approval history
2020-05-28Labeling · Supplement 15 · standardAP
2019-09-26Labeling · Supplement 19 · standardAP
2016-02-02Labeling · Supplement 14 · standardAP
2016-02-02Labeling · Supplement 13 · standardAP
2014-12-19Labeling · Supplement 12 · standardAP
2014-10-31Manufacturing (CMC) · Supplement 11AP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.